HC Wainwright Lowers Plus Therapeutics (NASDAQ:PSTV) Price Target to $2.00



HC Wainwright decreased their price objective on Plus Therapeutics from $3.00 to $2.00 and set a “buy” rating on the stock in a report on Monday.



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *